Fig. 1From: A real-world retrospective study of the use of Ki-67 testing and treatment patterns in patients with HR+, HER2− early breast cancer in the United StatesMultivariable logistic regression analyses. Forest plots showing the estimate values for the variables analyzed for association with (a) whether a patient was tested for Ki-67 (N = 567) and (b) a Ki-67 expression status ≥20% among those who were tested for Ki-67 (N = 130)Back to article page